McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
628.18
+7.04 (1.13%)
Nov 21, 2024, 1:49 PM EST - Market open
McKesson Employees
McKesson had 51,000 employees as of March 31, 2023. The number of employees decreased by 24,000 or -32.00% compared to the previous year.
Employees
51,000
Change (1Y)
-24,000
Growth (1Y)
-32.00%
Revenue / Employee
$6,474,255
Profits / Employee
$49,725
Market Cap
79.74B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2023 | 51,000 | -24,000 | -32.00% |
Mar 31, 2022 | 75,000 | -1,000 | -1.32% |
Mar 31, 2021 | 76,000 | -4,000 | -5.00% |
Mar 31, 2020 | 80,000 | 0 | - |
Mar 31, 2019 | 80,000 | 2,000 | 2.56% |
Mar 31, 2018 | 78,000 | 0 | - |
Mar 31, 2017 | 78,000 | 10,000 | 14.71% |
Mar 31, 2016 | 68,000 | -2,400 | -3.41% |
Mar 31, 2015 | 70,400 | 27,600 | 64.49% |
Mar 31, 2014 | 42,800 | -700 | -1.61% |
Mar 31, 2013 | 43,500 | 5,800 | 15.38% |
Mar 31, 2012 | 37,700 | 1,300 | 3.57% |
Mar 31, 2011 | 36,400 | 3,900 | 12.00% |
Mar 31, 2010 | 32,500 | 0 | - |
Mar 31, 2009 | 32,500 | -400 | -1.22% |
Mar 31, 2008 | 32,900 | 1,100 | 3.46% |
Mar 31, 2007 | 31,800 | 5,400 | 20.45% |
Mar 31, 2006 | 26,400 | 1,200 | 4.76% |
Mar 31, 2005 | 25,200 | 600 | 2.44% |
Mar 31, 2004 | 24,600 | 100 | 0.41% |
Mar 31, 2003 | 24,500 | 500 | 2.08% |
Mar 31, 2002 | 24,000 | 1,000 | 4.35% |
Mar 31, 2001 | 23,000 | 1,900 | 9.00% |
Mar 31, 2000 | 21,100 | -3,500 | -14.23% |
Mar 31, 1999 | 24,600 | 10,900 | 79.56% |
Mar 31, 1998 | 13,700 | 400 | 3.01% |
Mar 31, 1997 | 13,300 | 2,000 | 17.70% |
Mar 31, 1996 | 11,300 | -900 | -7.38% |
Mar 31, 1995 | 12,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
HCA Healthcare | 310,000 |
CVS Health | 300,000 |
Elevance Health | 104,900 |
Becton, Dickinson and Company | 73,000 |
The Cigna Group | 72,500 |
GSK | 70,212 |
Takeda Pharmaceutical | 49,281 |
Cencora | 46,000 |
MCK News
- 12 days ago - McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network - Seeking Alpha
- 14 days ago - These Analysts Boost Their Forecasts On McKesson Following Upbeat Earnings - Benzinga
- 14 days ago - McKesson Corporation (MCK) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - McKesson raises annual profit forecast on strength in its U.S. pharma segment - Reuters
- 14 days ago - McKesson Corporation Reports Fiscal 2025 Second Quarter Results and Raises Full Year Adjusted EPS Guidance - Business Wire
- 21 days ago - McKesson Corporation Declares Quarterly Dividend - Business Wire
- 6 weeks ago - McKesson Corporation: A Defensive Healthcare Value Stock Without A Patent Cliff - Seeking Alpha
- 6 weeks ago - InspiroGene by McKesson Unveils First-of-its-Kind Report on State of the Cell and Gene Therapy Landscape, Revealing Unparalleled Optimism Amidst Complex Challenges - Business Wire